Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma. - Wikidata - wikimedia - TriplyDB

Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma.

Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma.

http://www.wikidata.org/entity/Q34488803

about

Brainstem Glioma in Adults State of affairs in use of steroids in diffuse intrinsic pontine glioma: an international survey and a review of the literature DIPG in Children - What Can We Learn from the Past?Clinico-radiologic characteristics of long-term survivors of diffuse intrinsic pontine glioma.Management of diffuse pontine gliomas in children: recent developments.Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma.Vamorolone, a dissociative steroidal compound, reduces pro-inflammatory cytokine expression in glioma cells and increases activity and survival in a murine model of cortical tumor."Occult" post-contrast signal enhancement in pediatric diffuse intrinsic pontine glioma is the MRI marker of angiogenesis?MR imaging assessment of tumor perfusion and 3D segmented volume at baseline, during treatment, and at tumor progression in children with newly diagnosed diffuse intrinsic pontine glioma Brainstem glioma: a review.Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma.Magnetic resonance imaging is the preferred method to assess treatment-related skeletal changes in children with brain tumors.Primary brain tumors and posterior reversible encephalopathy syndrome Effect of time from diagnosis to start of radiotherapy on children with diffuse intrinsic pontine glioma Proton magnetic resonance spectroscopy predicts survival in children with diffuse intrinsic pontine glioma.Clinical development of VEGF signaling pathway inhibitors in childhood solid tumors.Automated volumetric growth plate measurement using magnetic resonance imaging for monitoring skeletal toxicity in children treated on investigational drug trials.Molecular profiling of childhood cancer: Biomarkers and novel therapies Motexafin-gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a children's oncology group phase 2 study.Diffuse intrinsic pontine glioma: poised for progress.The VEGF pathway in cancer and disease: responses, resistance, and the path forward.Phase I trial, pharmacokinetics, and pharmacodynamics of vandetanib and dasatinib in children with newly diagnosed diffuse intrinsic pontine glioma.Autophagy inhibition induces enhanced proapoptotic effects of ZD6474 in glioblastoma Phase I pharmacokinetic and pharmacodynamic study of pazopanib in children with soft tissue sarcoma and other refractory solid tumors: a children's oncology group phase I consortium report.Combining molecular targeted agents with radiation therapy for malignant gliomas Diffuse intrinsic pontine glioma-current status and future strategies.Brain tumors in children--current therapies and newer directions.Paediatric and adult malignant glioma: close relatives or distant cousins?Overcoming the blood-brain barrier in chemotherapy treatment of pediatric brain tumors.Vandetanib for the treatment of thyroid cancer: an update.Diffuse intrinsic pontine glioma: a reassessment.Pediatric diffuse intrinsic pontine glioma: can optimism replace pessimism?Diffuse intrinsic pontine glioma: time for therapeutic optimism.Receptor tyrosine kinase inhibitors: Are they real tumor killers?Measurable Supratentorial White Matter Volume Changes in Patients with Diffuse Intrinsic Pontine Glioma Treated with an Anti-Vascular Endothelial Growth Factor Agent, Steroids, and Radiation.Co-administration strategy to enhance brain accumulation of vandetanib by modulating P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp1/Abcg2) mediated efflux with m-TOR inhibitors.Discrepant longitudinal volumetric and metabolic evolution of diffuse intrinsic Pontine gliomas during treatment: implications for current response assessment strategies MRI Evaluation of Non-Necrotic T2-Hyperintense Foci in Pediatric Diffuse Intrinsic Pontine Glioma."Neurological complications of new chemotherapy agents".Gliomas in children.

P2860

Q26739232-C2B288F3-E3E9-48C7-82E5-9EB0D0D321C9 Q26749591-FF40D99D-2244-4E7F-9D66-9A57D32A693A Q26777843-C954F655-DD2C-495C-86BC-0D98CFDC9A69 Q30652433-59341204-3D38-410B-B83B-9963961DD448 Q34347540-68AB6174-CD04-479F-9086-14C7C3E63879 Q34359662-3D0BA498-7771-4AFF-8E84-841E3127205A Q34548198-7FBEE4A0-E518-46D9-97AF-A01B9A959AD3 Q34598854-B98D887F-5660-4E2A-B49D-BDD781693411 Q34598895-319555D3-5068-41A0-9BA8-558DE9820247 Q34628180-DB3FB20E-F307-41E8-B8EB-DDFFBEC78ECA Q34757990-4DC2471C-AB05-44AD-9644-33FF57F4113B Q35021664-7D2000AE-41BC-479A-840B-531AA884EE17 Q35206252-91B1C3F2-84CC-46C0-9FF2-44CCF0B94824 Q35230772-61876EED-59A1-47EA-8984-7D72FCAB4C96 Q35421487-E9BDF23B-77DC-42D5-99EA-DFBD09955446 Q35599819-CA3E34E4-A484-4EAF-8CC2-1AC670B6098D Q36226051-2845E738-6AF3-4469-886D-9213368612B8 Q36250783-26032DD6-E978-4CA5-9F8B-F905389A9C5A Q36485991-131C09D8-EE6D-44DE-88BE-FD70B2212669 Q36492719-DB6F95AD-4D8E-42DC-8CDB-81380F42FBF9 Q36526512-41FD859C-376A-49D8-8A22-4DDE04323A2C Q36936139-1B260B1F-9C87-4768-8162-775B1BD4F657 Q37003332-21A8D754-EBB6-41ED-B921-B7128B823631 Q37085863-531C2BB6-857F-4D2B-8475-E3E29C2FB7A1 Q37099594-8A010DA1-09A3-4535-B40E-863ACB72468F Q37870759-E0FD5605-30C2-465C-B7D2-102CBD3C00EC Q37980395-90552355-5598-4E69-8D2E-B86CFA881F65 Q38013990-CCD8581C-ECCE-4EEA-A95A-60ED63AC399B Q38133407-BEEAF8F0-8D65-4596-AB1A-C3EE3327CCAE Q38185691-C0322EED-457E-49B8-808F-EBEF3E0DD9AC Q38208998-D6E171AC-0622-468D-AD72-C1F33600276D Q38233425-45C9183B-600D-484D-B28C-89E3D48838A2 Q38264309-334AB9CE-7F8E-40E9-8CA4-CD12B4FF856D Q38365290-6E50B721-A08E-4D3F-A0CB-5F3730C33DB7 Q38827788-692CFF3D-4829-41C6-9132-97A094DE3CD8 Q39341824-8F53FB4B-AB47-4C3C-8E32-02BA2298F802 Q39580234-1DB30468-779E-449C-BE37-0A6553300DD5 Q39752215-8C0C76E3-DFF6-4BFA-B638-7CC1CBBBBA8E Q45069581-D24CBBFD-1E81-4E55-B0E8-D649A2C81309 Q45343976-E33B3D20-D828-46FB-8395-57880ADA1122

P2860

Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma.

http://www.wikidata.org/entity/Q34488803

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Phase I study of vandetanib du ...... fuse intrinsic pontine glioma.

@ast

Phase I study of vandetanib du ...... fuse intrinsic pontine glioma.

@en

Phase I study of vandetanib du ...... fuse intrinsic pontine glioma.

@nl

type

label

Phase I study of vandetanib du ...... fuse intrinsic pontine glioma.

@ast

Phase I study of vandetanib du ...... fuse intrinsic pontine glioma.

@en

Phase I study of vandetanib du ...... fuse intrinsic pontine glioma.

@nl

prefLabel

Phase I study of vandetanib du ...... fuse intrinsic pontine glioma.

@ast

Phase I study of vandetanib du ...... fuse intrinsic pontine glioma.

@en

Phase I study of vandetanib du ...... fuse intrinsic pontine glioma.

@nl

P1433

Q34488803-8A02F88A-058D-454B-AF65-778398E0257B

P1476

Q34488803-7B732583-ADF7-45ED-9548-84B694B5F61D

P2093

Q34488803-6F273F23-C3AB-45FF-97E9-7A098369D54F

Q34488803-7C914A96-590A-4AB1-ABE7-E11AC285AE80

Q34488803-98FC66F7-9CA4-48F1-97FE-360681513F52

Q34488803-9E71F795-2F83-4C2B-BF8B-21ED7FA439D1

Q34488803-A304BA4D-E5BA-4EC1-A9E7-A3A4F314B660

Q34488803-A41B4D35-CC15-4791-8FF6-E9DCCE4EEE4D

Q34488803-B5959589-2CFB-414F-B8D9-E037C793FDF6

Q34488803-B6B937E8-8547-4194-92BC-DF4F6A691553

Q34488803-EF22D67F-27C6-4E09-AFF6-97A96B4D87AB

Q34488803-F28FFA7C-C3CB-44AC-91F0-3BE9A3027B5C

P2860

Q34488803-0405324E-0DE5-4F4A-A885-F86A4D7BBEF0

Q34488803-092569B1-E07B-423C-BE68-6027C3A47C37

Q34488803-14929601-8035-45B1-951A-A0072C7F4A5F

Q34488803-1CCF94D2-0CA7-4FEC-938C-675A399C2236

Q34488803-1D116191-2E45-4179-A4F9-0FB8BF6FA36A

Q34488803-320126EE-1F63-4898-A22B-11F61554B6F4

Q34488803-3AB1CF9A-1097-4D1B-8CAC-8E5A630DCCB3

Q34488803-523ED27B-5026-40F9-9440-B532F3E316A5

Q34488803-6DBDF6A6-D1BB-4217-B7D6-201A2A01C8C3

Q34488803-7520CB8D-202C-4D43-BB23-005E3413CC68

P304

Q34488803-453A8806-758B-4383-B411-EAA295A801DA

P31

Q34488803-B3032EA9-A9AC-4E5D-9345-20DBA3C7D8A8

P356

Q34488803-9B71BCA1-02FD-4340-840D-D1290F37854A

P407

Q34488803-0CE01456-D727-40A3-9F13-72E25F4FC8E5

P433

Q34488803-308E0AC4-54D2-4520-A36D-DE41B158EB60

P478

Q34488803-255067D3-23AD-4C3A-AC7F-A3D67F66D394

P50

Q34488803-3477B13E-6965-412E-98F9-B30006B15B02

Q34488803-478F8174-537E-46B9-AC56-6D81B048C3DF

Q34488803-82952CD4-37AD-4CC2-BA65-61841609D6DC

P577

Q34488803-E1D8EE24-4441-4D8C-92D9-78A4848F6AE0

P5875

Q34488803-B3DEEF6E-776C-405C-9FC1-560D7AC6F1FD

P698

Q34488803-4793AA19-2DE8-4060-A110-D58678F53A0A

P921

Q34488803-41EAC362-6F4D-4C98-BE6B-D548B07CFF9D

Q34488803-B37947A9-D9A7-43D4-9239-EA927CB1DF93

P932

Q34488803-81B31D86-0CFE-487C-9A4B-68A9B13E80CD

P356

JCO.2010.30.3545

P1433

Journal of Clinical Oncology

P1476

Phase I study of vandetanib du ...... fuse intrinsic pontine glioma.

@en

P2093

Amar Gajjar

http://www.w3.org/2001/XMLSchema#string

Andrew M Davidoff

http://www.w3.org/2001/XMLSchema#string

Arzu Onar-Thomas

http://www.w3.org/2001/XMLSchema#string

Atmaram S Pai Panandiker

http://www.w3.org/2001/XMLSchema#string

Christopher Rowland

http://www.w3.org/2001/XMLSchema#string

Clinton F Stewart

http://www.w3.org/2001/XMLSchema#string

Michael Tagen

http://www.w3.org/2001/XMLSchema#string

Richard J Gilbertson

http://www.w3.org/2001/XMLSchema#string

Sue C Kaste

http://www.w3.org/2001/XMLSchema#string

Thomas E Merchant

http://www.w3.org/2001/XMLSchema#string

P2860

A reversible posterior leukoencephalopathy syndrome

Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

Diffuse brainstem glioma in children: critical review of clinical trials.

Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.

The contribution of epidermal growth factor receptor (EGFR) signaling pathway to radioresistance in human gliomas: a review of preclinical and correlative clinical data.

Phase I study of vandetanib with radiotherapy and temozolomide for newly diagnosed glioblastoma.

Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.

Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine glioma.

ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma.

P304

4762-4768

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2010.30.3545

http://www.w3.org/2001/XMLSchema#string

P407

P433

31

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Alberto Broniscer

P577

2010-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47336654

http://www.w3.org/2001/XMLSchema#string

P698

20921456

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

diffuse intrinsic pontine glioma

P932

3020706

http://www.w3.org/2001/XMLSchema#string